ASO Author Reflections: Neoadjuvant Chemotherapy Prior to CRS/HIPEC for Metachronous Colorectal Peritoneal Metastases: No Survival Gain and Increased Perioperative Risk
本文未提供摘要，请点击“查看全文”查看完整内容。